中国实用医药
中國實用醫藥
중국실용의약
CHINA PRACTICAL MEDICAL
2014年
33期
17-18
,共2页
凌小浩%黄振炎%黄进%陈少藩
凌小浩%黃振炎%黃進%陳少藩
릉소호%황진염%황진%진소번
慢性阻塞性肺疾病%二陈汤合三子养亲汤%肺功能
慢性阻塞性肺疾病%二陳湯閤三子養親湯%肺功能
만성조새성폐질병%이진탕합삼자양친탕%폐공능
Chronic obstructive pulmonary disease%Erchen decoction combined with Sanzi Yangqin decoction%Pulmonary function
目的:评价传统经方二陈汤合三子养亲汤治疗痰浊阻肺型慢性阻塞性肺疾病稳定期的疗效。方法60例痰浊阻肺型慢性阻塞性肺疾病患者,随机分为治疗组和对照组,各30例。对照组进行基础的西医治疗,治疗组在对照组的基础上加用二陈汤合三子养亲汤治疗。观察两组疗效。结果治疗组总有效率86.7%优于对照组56.7%(P<0.01)。用力肺活量(FVC)、一秒用力呼气容积(FEV1)比较,治疗组治疗后优于治疗前(P<0.05);深吸气量(IC)比较,治疗后优于治疗前(P<0.05),治疗组治疗后优于对照组(P<0.05)。结论二陈汤合三子养亲汤能够明显改善慢性阻塞性肺疾病患者喘息的症状,对于改善肺功能效果良好,值得推广。
目的:評價傳統經方二陳湯閤三子養親湯治療痰濁阻肺型慢性阻塞性肺疾病穩定期的療效。方法60例痰濁阻肺型慢性阻塞性肺疾病患者,隨機分為治療組和對照組,各30例。對照組進行基礎的西醫治療,治療組在對照組的基礎上加用二陳湯閤三子養親湯治療。觀察兩組療效。結果治療組總有效率86.7%優于對照組56.7%(P<0.01)。用力肺活量(FVC)、一秒用力呼氣容積(FEV1)比較,治療組治療後優于治療前(P<0.05);深吸氣量(IC)比較,治療後優于治療前(P<0.05),治療組治療後優于對照組(P<0.05)。結論二陳湯閤三子養親湯能夠明顯改善慢性阻塞性肺疾病患者喘息的癥狀,對于改善肺功能效果良好,值得推廣。
목적:평개전통경방이진탕합삼자양친탕치료담탁조폐형만성조새성폐질병은정기적료효。방법60례담탁조폐형만성조새성폐질병환자,수궤분위치료조화대조조,각30례。대조조진행기출적서의치료,치료조재대조조적기출상가용이진탕합삼자양친탕치료。관찰량조료효。결과치료조총유효솔86.7%우우대조조56.7%(P<0.01)。용력폐활량(FVC)、일초용력호기용적(FEV1)비교,치료조치료후우우치료전(P<0.05);심흡기량(IC)비교,치료후우우치료전(P<0.05),치료조치료후우우대조조(P<0.05)。결론이진탕합삼자양친탕능구명현개선만성조새성폐질병환자천식적증상,대우개선폐공능효과량호,치득추엄。
Objective To evaluate the curative effect of traditional Erchen decoction combined with Sanzi Yangqin decoction in the treatment of turbid phlegm obstructing lung type of chronic obstructive pulmonary disease in stable phase. Methods A total of 60 cases of turbid phlegm obstructing lung type of chronic obstructive pulmonary disease were randomly divided into treatment group and control group, with 30 cases in each group. The control group received basic Western medicine treatment, while the treatment group received additional treatment by Erchen decoction combined with Sanzi Yangqin decoction. The curative effects of the two groups were observed. Results The effective rate of the treatment group was 86.7%, which was better than 56.7%of the control group (P<0.01). The treatment group had better levels of forced vital capacity (FVC) and forced expiratory volume in 1s (FEV1) after the treatment than before it (P<0.05). Comparison of inspiratory capacity (IC) showed that it was better after treatment than before treatment (P<0.05), and it was better in the treatment group after treatment than in the control group (P<0.05). Conclusion The application of Erchen decoction combined with Sanzi Yangqin decoction can remarkably improve the breathing syndrome of patients with chronic obstructive pulmonary disease, and had obviously effect in improving pulmonary function. It is worthy of promotion.